Active	Status	Sponsor type	Region	Phase	Filter
10 Active 10 Inactive 20 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Bortolotto, Luiz Ap
OPTION TREAT, NCT05920005: Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension	Recruiting	3	698	RoW	candesartan cilexetil + chlorthalidone + amlodipine, Exforge HCT® (valsartan 160mg + hydrochlorothiazide 12.5mg + amlodipine 5mg)	Hospital Israelita Albert Einstein, Libbs Farmacêutica LTDA	Hypertension	12/23	07/24
Rochitte, Carlos E
No trials found
Moraes, Tercio L
No trials found
Pavlov, Valentin
No trials found